病例报告

双眼瞳孔残膜切除联合有晶状体眼后房型环曲面人工晶状体植入治疗先天性视力不佳一例

Bilateral pupil residual membrane resection combined with TICL implantation in the treatment of congenital poor vision: a case report

:770-774
 
该文报道一例30岁的男性患者因“双眼自幼视力不佳,强光下视物模糊加重4年余”就诊,经过眼部检查评估,诊断为双眼瞳孔残膜、双眼屈光不正。患者接受一期双眼瞳孔残膜切除、二期双眼行有晶状体眼后房型环曲面人工晶状体(toric implantable collamer lens,TICL)植入手术,术后视力恢复良好。文章回顾了该例患者的诊治过程,为临床屈光不正同时伴有瞳孔残膜患者的诊治提供参考。
A 30-year-old male patient presented at our institution with a history of poor vision in both eyes since childhood, exacerbated by blurriness under bright light for over four years. Following a comprehensive ophthalmic examination, the patient was diagnosed with bilateral pupillary membrane remnants and refractive errors. The patient underwent a two-stage surgical intervention, starting with the removal of the pupillary membrane remnants, followed by the implantation of toric implantable collamer lenses (TICL) in the posterior chamber of the lensless eyes. Postoperative outcomes were favorable, with significant improvement in visual acuity. This article reviews the therapeutic journey of the patient, offering insights into the diagnosis and management of individuals with concurrent refractive anomalies and pupillary membrane remnants, thereby contributing to the clinical discourse on the subject.
综述

前弹力层Inlay和Onlay移植治疗晚期圆锥角膜的进展

Progress on the treatment of advanced keratoconus with anterior elastic layer inlay and Onlay transplantation

:764-769
 
随着角膜疾病治疗技术的不断进步,前弹力层移植技术(包括Inlay和Onlay技术)已成为晚期圆锥角膜治疗的重要手段,能有效改善患者的角膜地形图和视力结果,稳定角膜扩张,提高患者的生活质量。该文综述了前弹力层移植技术的理论基础、移植物的来源与制备技术、手术技术、临床疗效以及相关并发症,为晚期圆锥角膜的治疗提供了新的视角。研究表明,这种先进的移植技术相较于传统方法,在减少手术风险、简化手术流程以及加快术后恢复方面具有明显优势,特别是在降低异体移植物排斥反应及手术并发症的风险上,前弹力层移植表现出色。Onlay技术作为一种近期开发的新方法,其独特优势是无需剖离角膜,更好地保护角膜结构。此外这种技术的高度适应性和可逆性,为患者提供了更多的治疗选择和更好的视觉恢复。尽管如此,技术细节如移植物的尺寸和形状定制、手术深度的最优化等方面仍需进一步研究和优化,以提高整体治疗效果。
With the continuous advancement of corneal disease treatment technology, Bowman layer transplantation (including Inlay and Onlay technology) has become an important means for the treatment of advanced progressive keratoconus, which can effectively improve the corneal topography and visual acuity of patients, stabilize corneal dilation, and improve the quality of life of patients. Tis article reviews the theoretical basis of Bowman layer transplantation, the source and preparation of grafs, surgical techniques, clinical efcacy, and related complications, which provides a new perspective for the treatment of advanced keratoconus. It is stated in the research that this advanced transplantation technique has significant advantages over traditional methods in reducing surgical risks, simplifying the surgical procedures, and improving postoperative recovery. Especially in reducing the risk of allograft rejection and surgical complications, the bowman layer transplantation performs excellently. As a novel developed method, Onlay technology has the unique advantage of eliminating the need to dissect the cornea, which beter protects the corneal structure. In addition, due to the highly adaptable and reversible nature of this technique, it provides patients with more treatment options and beter visual recovery. However, in terms of technical details such as customizing the size and shape of the transplant, optimizing the surgical depth, etc., it is needed to conduct further research and optimization to improve the overall treatment efect.
综述

激光周边虹膜切除术在原发性房角关闭治疗中的进展

Progress of laser peripheral iridotomy in the treatment of primary angle closure

:170-176
 
青光眼是全球第二大致盲眼病,第一大不可逆性致盲眼病,其中原发性闭角型青光眼(primary angle closure glaucoma,PACG)占25%。激光周边虹膜切除术(laser peripheral iridotomy,LPI)已成为PACG和原发性房角关闭的一线治疗。LPI机制为利用激光在周边虹膜上打孔,解除PACG的瞳孔阻滞,加深前房,扩大房角,恢复生理性房水排出途径,从而降低眼压。研究表明LPI在原发性房角关闭各个疾病进程中均能比较好的控制眼压,是相对安全的治疗方法。
Glaucoma is the second leading cause of blindness and the most common cause of irreversible blindness worldwide. Primary angle closure glaucoma (PACG) accounts for 25% of glaucoma. Laser peripheral iridotomy(LPI) has become the first line treatment for PACG and primary angle closure (PAC). The mechanism of LPI is to use laser to create a hole in peripheral iris to relieve pupil block, deepen anterior chamber, expand chamber angle,restore pathway of physiological aqueous discharge and reduce intraocular pressure. Studies have shown that LPI can control intraocular pressure well in all stages of PAC, which is safe for PAC.
论著

斜视患者手术治疗后的眼表状况

Ocular surface condition after squint surgery

:159-162
 
目的:探索斜视患者手术治疗后的眼表恢复状况。方法:选取2015年1月至2018年6月于如皋市广慈医院接受门诊手术治疗的92例水平性斜视患者为研究对象,共126眼,按照手术切口将患者分为3组,行角膜缘切口的42例52眼患者为A组,行跨肌止端切口的17例19眼患者为B组,行近穹窿切口的33例55眼患者为C组。再根据手术累及肌肉条数将患眼分为3组,行单条眼外肌的29眼手术者为单肌组,行2条眼外肌的42眼手术者为双肌组,行3条眼外肌的21眼手术者为三肌组。比较不同切口类型和肌肉累及数患者的眼表健康恢复时间。结果:A,B,C3组间首次泪膜破裂恢复时间、泪河高度时间差异有统计学意义(P<0.05);A组首次泪膜破裂恢复时间(14.33±3.26) d和泪河高度时间(14.54±1.58) d显著低于B组和C组,差异具有统计学意义(F=4.876,P=0.032;F=4.612,P=0.036)。单肌组,双肌组及三肌组3组间首次泪膜破裂恢复时间、泪河高度时间差异有统计学意义(P<0.05);单肌组的首次泪膜破裂恢复时间(13.42±3.57) d和泪河高度时间(8.65±1.62) d显著低于双肌组和三肌组,差异有统计学意义(F=4.975,P=0.028;F=5.024,P=0.025)。结论:手术累及的肌肉数和手术切口类型对术后眼表健康状况具有重要影响,近穹窿切口的手术方式和累及较少肌肉数量有助于患者术后眼部健康状况的恢复。
Objective: To explore the ocular surface recovery after surgical treatment of strabismus patients. Methods: A total of 92 patients (126 eyes) with strabismus who underwent surgery in our hospital from January 2015 to June 2018 were enrolled. The patients were divided into three groups according to the surgical incision, 42 patients (52 eyes)underwent limbal incision were in group A, 17 patients (19 eyes) underwent trans-muscle end-point incision in group B, and 33 patients (55 eyes) underwent proximal hernia incision in group C. According to the number of muscles involved in the operation, the sick eyes of patients were divided into three groups. The 29 eyes with a single extraocular muscle were a single muscle group, the 42 eyes with 2 extraocular muscles were a double muscle group, and the 21-eye treated with 3 extraocular muscles were a three-muscle group. The ocular surface health recovery time of patients with different incision types and muscle involvement were compared. Results: The first tear film rupture recovery time and tear river height time between group A, B, and C were significantly different,and the data were statistically significant (P<0.05); the first tear film rupture recovery time (14.33±3.26) d and tear river height time (14.54±1.58) d in group A were significantly lower than those in group B and C. The data were statistically significant (F=4.876, P=0.032; F=4.612, P=0.036). The first tear film rupture recovery time and tear river height time between the single, double and three muscle groups were significantly different, and the data were statistically significant (P<0.05); the first tear film rupture recovery time (13.42±3.57) d and tear river height time (8.65±1.62) d were significantly lower in the single muscle group than in the double muscle group and the third muscle group. The data were statistically significant (F=4.975, P=0.028; F=5.024, P=0.025). Conclusion:The number of muscles involved in the operation and the type of surgical incision have an important impact on the health of the ocular surface after surgery. The proximal ankle incision and less number of muscles involved would improve the postoperative recovery of eye health.
综述

超声睫状体成形术治疗不同类型青光眼的研究进展

Research progress in different types of glaucoma treatment with ultrasound cyclo-plasty

:518-525
 
超声睫状体成形术(ultrasound cyclo-plasty,UCP),是一种新型的睫状体治疗手术,目前已应用于治疗不同类型的青光眼。UCP通过微型高强度聚焦超声(high-intensity focused ultrasounds,HIFU)设备,高度选择性作用于睫状体,实现温和可控、稳定的降眼压(intraocular pressure,IOP)效果。相较于传统的睫状体破坏手术,UCP具有操作简单、耗时短、可重复性高及安全性高的特点。该文从UCP的由来、结构特点、作用机制、疗效、特点及安全性对UCP治疗不同类型青光眼的研究进展进行综述。
Ultrasound cyclo-plasty (UCP) is a novel technique for ciliary body surgery, which has been applied to treat different types of glaucoma. UCP works on the cilary body highly and selectively with the micro high-intensity focused ultrasounds (HIFU) to achieve a mild, controllable, and stable intraocular pressure(IOP) effect. Compared with the traditional ciliary body destruction surgery, UCP is simple operation, efficiency, high repeatability, and high safety.This article reviews the research progress in the UCP treating various types of glaucoma, from its origin, structural characteristics, mechanism, efficacy, characteristics, and safety.
综述

P2Y2受体激动剂治疗干眼的新进展

Recent advances in 3% diquafosol tetrasodium for dry eye

:254-259
 
2受体激动剂,3%地夸磷索四钠滴眼液,干眼" split="">P2Y2受体激动剂2受体激动剂,3%地夸磷索四钠滴眼液,干眼" split="">3%地夸磷索四钠滴眼液2受体激动剂,3%地夸磷索四钠滴眼液,干眼" split="">干眼
2 receptor agonist, 3% diquafosol tetrasodium, dry eye" split="">P2Y2 receptor agonist2 receptor agonist, 3% diquafosol tetrasodium, dry eye" split=""> 3% diquafosol tetrasodium2 receptor agonist, 3% diquafosol tetrasodium, dry eye" split=""> dry eye
干眼是指以泪膜稳态失衡为主要特征并伴有眼部不适症状的多因素眼表疾病。目前干眼的主要治疗手段包括药物治疗(人工泪液替代疗法、抗炎治疗、免疫抑制治疗)和必要时的手术干预治疗。地夸磷索四钠属于P2Y2受体激动剂,是一种治疗干眼的新型药物。它通过刺激位于眼表组织的P2Y2受体,促进泪液、黏液、脂质分泌,增强泪膜稳定性,从而改善干眼的症状和体征。
Dry eye refers to a series of chronic and progressive ocular surface diseases characterized by imbalanced tear film accompanied with ocular discomfort symptoms. The available methods mainly include pharmacotherapy (artificial tears replacement, anti-inflammatory, immunosuppressive therapy) and ophthalmic surgery. P2Y2 receptor agonist is a novel pharmaceutical agent for dry eye treatment, which could stimulate tear fluid secretion and mucin secretion through binding with P2Y2 receptors on the ocular surface, so that improve tear film stability and alleviate symptoms of dry eye. 3% diquafosol ophthalmic solution is the only P2Y2 receptor agonist available for dry eye.
论著

多焦点人工晶状体2.2 mm微切口植入治疗老年性白内障的临床观察

Clinical observation of multifocal intraocular lens with 2.2 mm microincision implantation for senile cataract

:229-236
 
目的:评估2.2 mm微切口白内障超声乳化摘除(phacoemulsification,Phaco)联合多焦点人工晶状体(multifocal intraocular lens,MIOLs)植入术治疗老年性白内障的临床安全性及疗效。方法:选取于2018年1月1日至2018年6月31日于佛山市第二人民医院行白内障Phaco联合人工晶状体植入的老年白内障患者。将其分为2组:A组31例35眼行2.2 mm微切口Phaco联合MIOLs植入术,B组31例38眼行3.0 mm标准切口Phaco联合单焦点IOLs植入术。2组患者均完善术前、术后的裸眼视力、角膜曲率、眼压、角膜内皮细胞数、离焦曲线等检查,同时记录其手术过程中的参数,进行比较。结果:A组与B组在手术过程中,总超乳时间、总超乳能量、超声乳化累积能量复合参数、有效超乳时间、平均超乳能量、总手术时间对比,差异均无统计学意义(均P>0.05)。2组患者术后较术前比较,角膜内皮细胞数均有所下降,差异有统计学意义(P<0.05);2组患者间在各时间点的比较,差异均无统计学意义(均P>0.05)。2组患者手术中均未出现后囊膜破裂等并发症。2.2 mm切口与3.0 mm切口术后均增加了角膜散光,与术前比较差异均有统计学意义(均P<0.01);2组间比较,差异无统计学意义(均P>0.05)。术后3个月,2组间裸眼远视力(uncorrected distance visual acuity,UCDVA)对比差异无统计学意义(t=?1.794,P=0.07);裸眼近视力(uncorrected near visual acuity,UCNVA)对比差异有统计学意义(t=?25.147,P<0.01)。A组的离焦曲线有2个峰值,分别位于0 D和?3.5 D附近,两峰值间形成一个下降平缓的平台;B组的离焦曲线只有1个峰值,位于0~0.5 D之间,峰值两端下降趋势明显。A组的脱镜率为77.42%(24/31),B组的脱镜率为12.90%(4/31),差异有统计学意义(χ2 =26.050,P<0.01);2组的总体满意度差异无统计学意义(χ2 =1.615,P=0.204)。结论:2.2 mm同轴微切口白内障手术在临床上安全性良好,联合植入MIOLs有较好的疗效,可于临床上广泛推广。
Objective: To evaluate the clinical safety and curative effect of phacoemulsification (Phaco) combined with multifocal intraocular lens (MIOLs) implantation in the treatment of senile cataract with 2.2 mm microincision cataract. Methods: The cataract patients who underwent phacoemulsification and intraocular lens implantation in our hospital were selected from January 1, 2018 to June 31, 2018. They were divided into two groups: group A with 31 patients (35 eyes) undergoing 2.2 mm micro-incision Phaco combined with MIOLs, while group B with 31 patients (38 eyes) undergoing 3.0 mm standard incision Phaco combined with single focus IOLs.The preoperative and postoperative uncorrected visual acuity, corneal curvature, intraocular pressure, corneal endothelium number, and defocus curve were recorded in both groups. The parameters during the operation were also recorded and compared. Results: There was no statistically significant difference in the parameters including total phacoemulsification time, total phacoemulsification energy, phacoemulsification cumulative energy compound parameters, effective phacoemulsification time, average phacoemulsification energy, total surgery time between group A and group B during the operation (all P>0.05). Compared with preoperative, the number of corneal endothelial cells decreased both in the two groups after surgery. The difference was statistically significant (P<0.05). There was no significant difference between the two groups at any time (all P>0.05). There were no complications such as posterior capsule rupture during operation in both groups. The corneal astigmatism was increased after operation both in the 2.2 mm incision and 3.0 mm incision, and the difference was statistically significant compared with pre-operation (both P<0.01). There was no significant difference between the two groups (all P>0.05). At 3 months postoperatively, there was no significant difference in uncorrected distance visual acuity (UCDVA) between the two groups (t=?1.794, P=0.07), and the difference was statistically significant in the uncorrected near visual acuity (UCNVA) (t=?25.147, P<0.01). Defocus curve: The defocus curve of group A had two peaks, which are located near 0 D and ?3.5 D, forming a flat platform with a descent between the two peaks.The defocus curve of group B had only one peak, located at 0–0.5 D, and the downward trend at both ends of the peak was obvious. The rate of off-glasses and satisfaction: the rate of off-glasses in group A was 77.42% (24/31),and the rate of dislocation in group B was 12.90% (4/31). The difference was statistically significant (χ2 =26.050,P<0.01). There was no significant difference in overall satisfaction between the two groups (χ2 =1.615, P=0.204).Conclusion: The 2.2 mm coaxial microincision cataract surgery yields high clinical safety, and the combined implantation of multi-focal intraocular lens has good curative effect and can be widely promoted in clinical practice.
综述

热敷治疗睑板腺功能障碍的研究进展

Research progress of warm compresses in the treatment of meibomian gland dysfunction

:935-941
 
睑板腺功能障碍(meibomian gland dysfunction,MGD)是眼科常见疾病,是蒸发过强型干眼的主要原因。基于人群流行病学的调查显示:MGD亚洲的发病率为46.2%~69.3%。目前,MGD治疗的方式包括眼睑清洁、热敷、睑板腺按摩、人工泪液、抗生素等,其中热敷为常用的家庭治疗方法。由于不同的热敷方式、温度、时间、频次及依从性,导致应用热敷治疗MGD到目前为止还没有统一标准。另外,热敷的不良反应如视物模糊、皮肤烫伤等,也没有引起临床足够重视。因此,为提高热敷的临床疗效及减少其不良反应,未来进行热敷的规范化指导或治疗很有必要。
Meibomian gland dysfunction (MGD) is a common ophthalmic disease, which is the main cause of evaporative dry eye. Population-based studies have suggested that the prevalence of MGD is high in Asia, with a reported incidence of 46.2% to 69.3%. Current modalities of MGD treatment include lid hygiene, warm compresses,massage, artificial lubricants, systemic and topical antibiotics, etc., among which warm compress is a common at-home treatment. Due to different eyelid warming methods, temperature, durations of heat application, frequency and compliance, there is no uniform standard for the application of warm compress to the treatment of MGD.In addition, adverse events of warm compress, such as blurred vision and thermal damage, have not attracted enough attention in clinical practice. Therefore, in order to improve the clinical efficacy of warm compress and reduce its adverse events, it is necessary to conduct standardized guidance or treatment of warm compress in the future. Based on the above considerations, this article will briefly review the application of warm compress to the treatment of MGD.
论著

中药超声雾化联合针灸治疗睑板腺功能障碍的临床疗效

Clinical effect of ultrasonic atomization of traditional Chinese medicine combined with acupuncture on meibomain gland dysfunction

:897-904
 
目的:观察中药超声雾化联合针灸治疗睑板腺功能障碍(meibomain gland dysfunction,MGD)的临床疗效。方法:选取在新华医院就诊的7 7例(154眼)双 眼MGD患者,随机分为对照组(27例5 4眼)、中药超声雾化治疗组(雾化组;2 5例5 0眼)和中药超声雾化联合针灸治疗组(联合治疗组;2 5例5 0眼)。对照组接受睑板腺按摩治疗,雾化组在睑板腺按摩的基础上行中药超声雾化治疗,联合治疗组为进一步加用针灸治疗,治疗周期为4周。治疗前后收集患者双眼泪膜破裂时间(tear breakup time,BUT)、双眼基础泪液分泌试验数据(Schirmer I test,SIT)、双眼角膜荧光素染色评分(fluorescent,FL)、睑板腺分泌物性状评分(Meibomian Glandyielding Secretion Score,MGYSS)、睑缘异常评分(Eyelid Margin Abnormality Score,EMAS)以及主观症状积分等资料,并评价临床疗效。结果:治疗前三组BUT、SIT、F L、MGYSS、EMAS和主观评价得分等组间差异均无统计学意义(均P >0.05)。治疗4周后,各组受试者的BUT、SIT、F L评分、MGYSS评分、EMAS评分和主观评价评分与治疗前相比差异均具有统计学意义(均P < 0.05);联合治疗组的上述指标分别与雾化组及对照组相比,差异均有统计学意义(P <0.05)。治疗后对照组的总有效率为51.85%(28眼/54眼),雾化组为84%(42眼/50眼),联合治疗组为96%(48眼/50眼),联合治疗组总有效率与雾化组相比差异有统计学意义(P <0.05)。结论:中药超声雾化联合针灸治疗在改善MGD患者的睑板腺功能和减轻患者的干眼症状方面具有较好的临床疗效。
Objective: To observe the clinical efficacy of ultrasonic atomization fumigation of traditional Chinese medicine combined with acupuncture in the treatment of meibomian gland dysfunction (MGD). Methods: A total of 77 MGD patients (154 eyes) in Xinhua Hospital were selected and randomly divided into a control group (27 cases,54 eyes), a ultrasonic atomization of traditional Chinese medicine group (atomization group; 25 cases, 50 eyes),and a ultrasonic atomization of traditional Chinese medicine combined with acupuncture group (combined treatment group; 25 cases, 50 eyes). The control group received meibomian gland massage, the atomization group received meibomian gland massage and ultrasonic atomization of traditional Chinese medicine, and the combined treatment group received additional acupuncture treatment. The treatment period was 4 weeks. Tear breakup time (BUT), basal tear secretion test data (Schirmer I Test, SIT), corneal fluorescein staining score (FL), and Meibomian Gland Yielding Secretion Score (MGYSS), Eyelid Margin Abnormality Score (EMAS), Subjective Symptom Score (SSS) were collected and conduct clinical efficacy were evaluated. Results: There were no significant differences in BUT, SIT, FL, MGYSS, EMAS and SSS among the three groups (all P>0.05).After treatment of 4 weeks, the BUT, SIT, FL, MGYSS, EMAS and SSS in each group were improved significantly compared to baseline (P<0.05). The above indicators in combined treatment group were significantly different from atomization group (P<0.05) and control group (P<0.05). The total effective rates after treatment were 51.85% (28/54) in control group, 84% (42/50) in atomization group, and 96% (48/50) in combined treatment group. The difference in total effective rate between combined treatment group and atomization group was significant (P<0.05). Conclusion: Ultrasonic atomization of traditional Chinese medicine combined with acupuncture presents good clinical effects in improving the meibomian gland function of patients with MGD and alleviating the dry eye symptoms.
论著

睑结膜乳头切除联合自体游离球结膜瓣移植术治疗春季角结膜炎

Clinical efficacy of surgical resection of conjunctival papillae combined with autologous conjunctival graft in treatment of vernal keratoconjunctivitis

:894-896
 
目的:探讨睑结膜乳头切除联合自体游离结膜瓣移植术治疗春季角结膜炎的临床效果。方法:在显微镜下对11例(22眼)春季角结膜炎患者行睑结膜乳头切除联合自体游离结膜瓣移植术,观察治疗效果。结果:术后随访36~48个月,11例(22眼)春季角结膜炎患者中,治愈19眼(86.36%),有效2眼(9.09%),无效1眼(4.55%),总有效率95.45%。结论:睑结膜乳头切除联合自体游离结膜瓣移植术是治疗春季角结膜炎安全、有效的方法。
Objective: To evaluate the efficacy and safety of surgical resection of conjunctival papillae combined with autologous conjunctival graft in the treatment of vernal keratoconjunctivitis (VKC). Methods: All 11 cases (22 eyes) with VKC were treated with surgical resection of conjunctival papillae in combination with autologous conjunctival graft. Clinical efficacy and safety were evaluated. Results: After 36 to 48 months of follow-up, 19 eyes were cured (86.36%), 2 eyes were improved (9.09%), and 1 eye was ineffective (4.55%). The total effective rate
was 95.45%. Conclusion: Surgical resection of conjunctival papillae combined with autologous conjunctival graft is efficacious and safe in the treatment of VKC.
其他期刊
  • 眼科学报

    主管:中华人民共和国教育部
    主办:中山大学
    承办:中山大学中山眼科中心
    主编:林浩添
    主管:中华人民共和国教育部
    主办:中山大学
    浏览
  • Eye Science

    主管:中华人民共和国教育部
    主办:中山大学
    承办:中山大学中山眼科中心
    主编:林浩添
    主管:中华人民共和国教育部
    主办:中山大学
    浏览
推荐阅读
出版者信息